-+ 0.00%
-+ 0.00%
-+ 0.00%

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

Benzinga·04/11/2025 09:16:00
Listen to the news

Shares of argenx SE (NASDAQ:ARGX) rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

argenx shares jumped 5.1% to $573.88 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • MSP Recovery, Inc. (NASDAQ:MSPR) rose 167% to $3.43 in pre-market trading as the company announced strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth.
  • Sharps Technology, Inc. (NASDAQ:STSS) surged 73.6% to $0.0318 in pre-market trading after jumping 30% on Thursday.
  • Enzo Biochem, Inc. (NYSE:ENZ) gained 26.5% to $0.3300 in pre-market after dipping 22% on Thursday.
  • Actelis Networks, Inc. (NASDAQ:ASNS) rose 26.4% to $0.8198 in pre-market trading. Actelis Networks recently announced it received a new order to modernize Orange County’s traffic infrastructure.
  • Venus Concept Inc. (NASDAQ:VERO) rose 25.6% to $5.10 in pre-market trading. Venus Concept announced closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules.
  • DMC Global Inc. (NASDAQ:BOOM) gained 21.7% to $7.90 in pre-market trading.
  • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 19.1% to $5.37 in pre-market trading.
  • Certara, Inc. (NASDAQ:CERT) surged 18.1% to $12.41 in pre-market trading after gaining 8% on Thursday.
  • Simulations Plus, Inc. (NASDAQ:SLP) gained 13.7% to $29.23 in pre-market trading. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.

Losers

  • AlTi Global, Inc. (NASDAQ:ALTI) fell 57.3% to $1.20 in pre-market trading after declining around 6% on Thursday.
  • cbdMD, Inc. (NYSE:YCBD) shares tumbled 38.9% to $0.1701 in pre-market trading. CbdMD announced shareholder approval of automatic conversion of series a preferred stock and other results from annual meeting.
  • Nexa Resources S.A. (NYSE:NEXA) fell 32% to $4.01 in today's pre-market trading.
  • Organovo Holdings, Inc. (NASDAQ:ONVO) shares fell 27.1% to $1.59 in pre-market trading.
  • Palatin Technologies, Inc. (NYSE:PTN) fell 16.8% to $0.3510 in pre-market trading after the company announced it received a NYSE American notice of delisting.
  • Betterware de México, S.A.P.I. de C.V. (NYSE:BWMX) shares fell 24% to $8.21 in pre-market trading. Betterware de México will report its first quarter results after the U.S. market close on Thursday, April 24.
  • Solaris Resources Inc. (NYSE:SLSR) shares dipped 22.3% to $2.20 in pre-market trading.
  • InnovAge Holding Corp. (NASDAQ:INNV) fell 14.9% to $2.35 in pre-market trading.
  • Costamare Inc. (NYSE:CMRE) dipped 14.3% to $7.42 in pre-market trading after falling 5% on Thursday.
  • Maze Therapeutics, Inc. (NASDAQ:MAZE) declined 12.8% to $6.62 in pre-market trading after falling 5% on Thursday.

Now Read This:

Photo via Shutterstock